Skip to Main Content

Paper Details

Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent.
Cancer Epidemiol Biomarkers Prev
11
2011
A35931C, CCND1, CCND1 (G870A), CCND1 G870A, CCND1-870, ERCC2, ERCC2 35931, ERCC2 Lys751Gln, G870A, IMPACT ERCC2, IMPACT ERCC2 A35931C, Lys751Gln, Pro241Pro, SCCHN, advanced-stage squamous cell carcinoma of the head and neck, patients, rs13181, rs9344, squamous cell carcinoma of the head and neck, stage III-IV cancers, tumor

Datasets